USSTOCK.TODAY
Market Closed
Log in Sign up
Company overview

AUNA — What Does the Company Do? Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters at a Glance

Updated June 18, 2026 · First published April 14, 2026

AUNA (AUNA) is a Latin American healthcare facilities company operating hospital networks and prepaid healthcare plans in Peru, Mexico, and Colombia. It is specialized in treating high-complexity conditions such as oncology and cardiology, with revenue and share price moves that are highly sensitive to both healthcare sector growth and emerging-market currency variables.

Briefs · earnings · signals, first Subscribe

🏢 What kind of company is AUNA?

AUNA (AUNA) is a Latin American–based healthcare facilities company that operates hospitals and clinics alongside prepaid healthcare plans across Peru, Mexico, and Colombia. It is focused on treating high-cost, high-complexity conditions in oncology, cardiology, orthopedics, and neurology, and pursues a prevention-oriented, integrated healthcare model.

Its two main pillars are healthcare services from hospital and clinic operations and Peru's prepaid healthcare plan Oncosalud. With a regionally diversified platform spanning three countries, the company is strengthening its position in the Latin American private healthcare market.

💰 How does AUNA make money?

Business SegmentRevenue ShareDescription
Healthcare ServicesCoreRevenue from hospital and clinic operations in Peru, Mexico, and Colombia
Prepaid Healthcare PlansKey Growth DriverMembership-based prepaid healthcare plans including Peru's Oncosalud

Hospital and clinic operations revenue, together with membership income from prepaid healthcare plans, forms the twin backbone of AUNA's revenue, characterized by steady cash flows underpinned by stable demand for medical services. While local-currency revenue in Peru and Colombia is expanding, Mexico is going through a stabilization phase, making the regionally diversified platform a buffer against individual country volatility. Operating margin tends to fluctuate with FX translation effects and country-specific cycles.

📐 AUNA Market Cap and Company Scale

Market capitalization stands at $382.6M, with a workforce of 15,254 people.

As a small- to mid-cap healthcare company focused on the Latin American medical facilities market, AUNA sits in a comparable bucket to US-listed hospital and surgical services operators. Through its hospital network spread across three countries and its prepaid plan membership base, the company is pursuing steady cash flow generation and deleveraging in parallel.

📈 AUNA Outlook and Share Price Trends

1-Year Price Performance
Analyst Consensus
1.4
Sell Hold Strong Buy
Target Price $8 +48.4% Current $5
52-Week Price Range
$5
Low $4 High $7
vs. low +26.41% vs. high -24.53%

The expansion of private healthcare demand in Latin America and growth in prepaid plan memberships are the core medium- to long-term drivers. Stabilization of the Mexico business and deeper penetration of the private insurance market are acting as variables for revenue and margin recovery, while local-currency revenue growth in Peru and Colombia is feeding into the growth trajectory. Over the near term, emerging-market FX volatility, local macro and regulatory conditions, and acquisition-related debt burdens can act as potential sources of volatility.

  • Expansion of private healthcare demand in Latin America
  • Growth in prepaid healthcare plan memberships
  • Mexico business stabilization and insurance market penetration

⚔️ AUNA Core Strengths and Risks

A three-country diversified hospital network and an integrated prepaid plan model are its strengths, while emerging-market FX exposure and debt burden are its core risks.

💪 Core Strengths

Integrated Healthcare Model
Combines hospital and clinic operations with prepaid healthcare plans to deliver a revenue structure that spans prevention through treatment.
Geographic Diversification
Revenue is spread across Peru, Mexico, and Colombia, lowering dependence on any single country.
High-Complexity Specialization
Capability in treating high-cost conditions such as oncology, cardiology, and neurology secures differentiated demand.

⚠️ Core Risks

FX Volatility
Exposure to currency swings during USD translation of emerging-market-denominated revenue.
Debt Burden
Debt accumulated through acquisition-led expansion represents a financial burden.
Local Regulation and Macro
Healthcare regulation and macroeconomic swings across the three countries affect revenue.

🔄 AUNA Competitors and Related Stocks (Beneficiaries)

As a hospital and medical services operator, a directly comparable peer is SGRY, which runs a network of surgical facilities. Related tickers include THC, a global hospital and ambulatory care operator, and UHS, a diversified healthcare services provider — grouped within the same healthcare services theme and sharing the medical facilities cycle.

Competitors
TickerCompanyPriceChangeMarket CapP/EPBRROEDividend Yield
SGRYSGRYSurgery Partners Inc$14.38+1.8%$1.9B-1.1-5.18%-
Related stocks (beneficiaries)
TickerCompanyPriceChangeMarket CapP/EPBRROEDividend Yield
THCTHCTenet Healthcare Corp$263.69+0.1%$21.2B10.24.653.31%-
UHSUHSUniversal Health Services Inc$174.83+1.2%$10.3B7.11.420.99%0.47%

✅ AUNA Investor Checklist

Key items to monitor when considering an investment in AUNA. Growth in Latin American healthcare demand and progress on Mexico business stabilization are the near- and medium-term variables, while emerging-market FX trends and deleveraging progress are also worth tracking.

ChecklistWhat to ConfirmCurrent Status
🏥 Hospital OperationsRevenue trends at hospitals and clinics across the three countriesCountry-by-country recovery phase
💵 Prepaid PlansMembership growth in prepaid healthcare including OncosaludExpanding trend
💱 FX ExposureUSD translation impact on emerging-market-currency revenueNeeds monitoring
📉 Financial HealthDeleveraging and capital efficiency trajectoryImprovement needs monitoring

Emerging-market FX volatility and acquisition-related debt accumulation are the key near-term risks. If the Mexico business recovery is delayed beyond expectations, profitability improvement could be pushed out, and healthcare regulation and macroeconomic swings across the three countries will also act as revenue volatility factors.

As an integrated healthcare company combining Latin American medical facilities with prepaid healthcare plans, growth recovery is anticipated from its regionally diversified platform and the Mexico stabilization phase. However, given the size of the emerging-market FX and debt variables, a scaled buying approach and a long-term horizon are recommended.

Briefs · earnings · signals, first Subscribe
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →